Characterization of a new model of parkinson's diisease induced by expression of alpha-synuclein in the midbrain.

Project Information

Grant agreement ID: QLK6-CT-2001-51860

Project closed

Start date 1 August 2002

End date 31 July 2004

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 150 804,00

EU contribution € 150 804,00

Coordinated by

LUND UNIVERSITY
Sweden

Objective

Temporal biochemical, molecular and behavioural characterization of the new Parkinson model. Study of the potential of GDNF retrovirus as a therapeutic strategy. Analysis of the susceptibility to 6-OH-dopamine of the dopaminergic system in the model.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › basic medicine › neurology › parkinson

You need to log in or register to use this function

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

LUND UNIVERSITY

• EU contribution: No data
• Address: Paradisgatan 2 ; 221 00 LUND ; Sweden
• Total cost: No data